The revenue of Intravenous Infusions Plc (IIPLC) increased significantly by 54.3% in 2023.

Compiled By: Prince Henry Danquah, Bora Capital Advisors Ltd.

Intravenous Infusions Plc (IIPLC) recorded a strong increase in revenue by  54.3% in 2023, following a 10% revenue decrease in 2022 financial year.

The increase in revenue is attributed to the deliberate pursuit of new strategies and policies aimed at maximizing revenues and efficiency, driven by improvement in controls.

Despite the marginal improvement in economic indicators recorded in 2023,  IIPLC chalked some successes in enhancing value to shareholders.

The existing controls were strengthened, and new ones were introduced.

This resulted in an increase in operational efficiency at all levels of the organizational value chain. 

Source: newsthemegh.com